Students explore nuclear facilities in virtual reality and learn about the ethical dimensions of nuclear technology in a ...
The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...
SESAUA annual meeting featured a bladder cancer session and a presentation by Dr. William Huang discussing results from the ENVISION trial assessing primary chemoablation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback